Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Subscription Receivable
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   18,045,029          
Beginning balance at Dec. 31, 2023 $ 49,383 $ 18 $ 118,694   $ (5,029) $ (64,000) $ (300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on marketable securities 160           160
Stock-based compensation 1,589   1,589        
Net income (loss) (6,265)       (6,265)    
Ending balance (in shares) at Mar. 31, 2024   18,045,029          
Ending balance at Mar. 31, 2024 $ 44,867 $ 18 120,283   (11,294) (64,000) (140)
Beginning balance (in shares) at Dec. 31, 2024 29,874,029 29,874,029          
Beginning balance at Dec. 31, 2024 $ 7,353 $ 23 129,921 $ 0 (58,393) (64,000) (198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common shares and treasury shares for cash, net of offering cost (in shares)   11,315,000          
Issuance of common shares and treasury shares for cash, net of offering cost 3,278 $ 6 (10,605) (480)   14,357  
Issuance of common stock as commitment fee for future financing (in shares)   352,176          
Unrealized gain (loss) on marketable securities 0            
Stock-based compensation 521   521        
Net income (loss) $ 3,966       3,966    
Ending balance (in shares) at Mar. 31, 2025 41,541,205 41,541,205          
Ending balance at Mar. 31, 2025 $ 15,118 $ 29 $ 119,837 $ (480) $ (54,427) $ (49,643) $ (198)